2m 2m 2m 2m 2m 2m 2m
ORUKA THERA (ORKA)
NASDAQ
$95.93+$3.55 (+3.84%)
Price as of Sep 14, 2026 7:31 PM EDT- $6.1BMarket Cap
- 499.87%1-Year Change
- BiotechnologyIndustry
ORUKA THERA (ORKA)
$95.93+$3.55 (+3.84%)
ORKA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $92.38 | ||
Change | +$0.73 (+0.80%) | ||
Open | $93.40 | ||
High | $94.29 | ||
Low | $90.48 | ||
Previous Close | $91.65 | ||
Volume | 585,301 | ||
30-Day Average Volume | 785,393 | ||
1-Week Change | -0.14% | ||
1-Month Change | -11.75% | ||
1-Year Change | 499.87% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 66.2M | ||
Total Assets | $1.1B | ||
Market Cap | $6.1B | ||
Enterprise Value | $5.8B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$41.2M | ||
Free Cash Flow | -$33.1M | ||
EBIT | -$41.2M | ||
EBITDA | -$41.2M | ||
Net Working Capital | $861.6M | ||
EPS | -$0.55 | ||
Enterprise Value/EBITDA | -142 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 5 | ||
P/E | -168 | ||
PEG | 12 | ||
Price/Free Cash Flow | -185 | ||
Price/Operating Cash Flow | -185 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue